BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 7614989)

  • 1. The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m.
    Pedersen LO; Stryhn A; Holter TL; Etzerodt M; Gerwien J; Nissen MH; Thøgersen HC; Buus S
    Eur J Immunol; 1995 Jun; 25(6):1609-16. PubMed ID: 7614989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the interactions between MHC class I subunits: a systematic approach for the engineering of higher affinity variants of beta 2-microglobulin.
    Shields MJ; Assefi N; Hodgson W; Kim EJ; Ribaudo RK
    J Immunol; 1998 Mar; 160(5):2297-307. PubMed ID: 9498770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound.
    Parker KC; DiBrino M; Hull L; Coligan JE
    J Immunol; 1992 Sep; 149(6):1896-904. PubMed ID: 1517560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High occupancy binding of antigenic peptides to purified, immunoadsorbed H-2Db beta 2m molecules.
    Burshtyn DN; Barber BH
    J Immunol; 1993 Sep; 151(6):3070-81. PubMed ID: 8397250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of peptide binding to purified antibody-bound H-2Db and H-2Db beta 2m complexes.
    Burshtyn DN; Barber BH
    J Immunol; 1993 Sep; 151(6):3082-93. PubMed ID: 7690793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
    Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
    J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous beta 2-microglobulin is required for antigenic peptide binding to isolated class I major histocompatibility complex molecules.
    Kane KP; Sherman LA; Mescher MF
    Eur J Immunol; 1991 Sep; 21(9):2289-92. PubMed ID: 1889467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules.
    Olsen AC; Pedersen LO; Hansen AS; Nissen MH; Olsen M; Hansen PR; Holm A; Buus S
    Eur J Immunol; 1994 Feb; 24(2):385-92. PubMed ID: 8299688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism at position nine of the MHC class I heavy chain affects the stability of association with beta 2-microglobulin and presentation of a viral peptide.
    Ribaudo RK; Margulies DH
    J Immunol; 1995 Oct; 155(7):3481-93. PubMed ID: 7561043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar).
    Zhao H; Hermsen T; Stet RJ; Skjødt K; Savelkoul HF
    Mol Immunol; 2008 Mar; 45(6):1658-64. PubMed ID: 18206244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression.
    Otten GR; Bikoff E; Ribaudo RK; Kozlowski S; Margulies DH; Germain RN
    J Immunol; 1992 Jun; 148(12):3723-32. PubMed ID: 1602127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domain.
    Lee L; McHugh L; Ribaudo RK; Kozlowski S; Margulies DH; Mage MG
    Eur J Immunol; 1994 Nov; 24(11):2633-9. PubMed ID: 7957555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
    Majlessi L; Bordenave G
    Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules.
    Kozlowski S; Takeshita T; Boehncke WH; Takahashi H; Boyd LF; Germain RN; Berzofsky JA; Margulies DH
    Nature; 1991 Jan; 349(6304):74-7. PubMed ID: 1985269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
    Sibille C; Gould K; Hämmerling G; Townsend A
    Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-induced conformational change of the class I heavy chain.
    Elliott T; Cerundolo V; Elvin J; Townsend A
    Nature; 1991 May; 351(6325):402-6. PubMed ID: 2034289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide interaction with a class I major histocompatibility complex-encoded molecule: allosteric control of the ternary complex stability.
    Gakamsky DM; Bjorkman PJ; Pecht I
    Biochemistry; 1996 Nov; 35(47):14841-8. PubMed ID: 8942647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines.
    Anderson KS; Alexander J; Wei M; Cresswell P
    J Immunol; 1993 Oct; 151(7):3407-19. PubMed ID: 8376783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.